• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

insulin

Eli Lilly to start rollout of Tempo personalized diabetes management platform

November 9, 2022 By Chris Newmarker

Marketing image of Eli Tempo personalized diabetes management platform

Eli Lilly and Co. (NYSE: LLY) recently announced it will soon roll out its Tempo personalized diabetes management platform in the U.S. The pharma giant described Tempo as its first connected platform. It includes three components: the Tempo Smart Button, a compatible TempSmart app, and the prefilled Tempo Pen insulin pen. The goal is personalized […]

Filed Under: Diabetes, Featured Tagged With: digital health, Eli Lilly, insulin

This robotic capsule could deliver large-protein drugs like insulin

September 28, 2022 By Sean Whooley

MIT Robot Drug Delivery

Researchers at the Massachusetts Institute of Technology (MIT) developed a new drug capsule with a robotic cap for improved drug delivery. Large-protein drugs generally can’t pass through the mucus barrier that lines the digestive tract. Insulin and most other “biologic drugs” with proteins or nucleic acids thus must be injected or administered in a hospital, […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development, Technology Tagged With: Diabetes, insulin, Massachusetts Institute of Technology, robotics

UnitedHealthcare to eliminate out-of-pocket costs on insulin, other prescription drugs

July 15, 2022 By Sean Whooley

Unitedhealthcare logo

UnitedHealthcare announced today that it will eliminate out-of-pocket costs in standard fully insured group plans for certain prescription drugs. Insulin, among a number of drugs used to treat emergencies including severe allergic reactions, hypoglycemia, opioid overdoses, and acute asthma attacks will be included in the new standard offering. Along with insulin, epinephrine (for severe allergic […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: insulin, UnitedHealthcare

California aims to produce inexpensive insulin

January 11, 2022 By Brian Buntz

Diabetes

California Governor Gavin Newsom has signaled that the state would pursue manufacturing insulin to offer the hormone at a reduced cost to people with diabetes. “Insulin should not drain your bank account,” Newsom shared over Twitter. Newsom has also made contract manufactured insulin part of the proposed budget planning for the fiscal year 2022. Get […]

Filed Under: Diabetes Tagged With: California, insulin

Nominations open for the Leonard Award celebrating 100 years of insulin

June 30, 2021 By Brian Buntz

Eli Lilly

Eli Lilly and Company (NYSE:LLY) is looking for nominations for its inaugural Leonard Award, which highlights advances in diabetes management. The company will select five winners and donate $100,00 to the non-profit Life for a Child, which provides medicines and supplies to children and youth with type 1 diabetes in developing countries.  Lilly is launching the […]

Filed Under: Diabetes, Featured Tagged With: Eli Lilly, insulin, Leonard Award, Life for a Child, type 1 diabetes

Walmart teams up with Novo Nordisk to launch private-brand analog insulin 

June 29, 2021 By Brian Buntz

Walmart/Novo-Nordisk

Walmart (NYSE:WMT) is launching what it describes as the first private label analog insulin. The company estimates the insulin products will save customers between 58% and 70% of the cost of branded insulin. Novo Nordisk (NYSE:NVO) will manufacture the analog insulin, which is a type of lab-grown insulin genetically engineered to optimize glucose control. The […]

Filed Under: Diabetes Tagged With: Diabetes, insulin, Novo Nordisk

Researchers reverse diabetes in mice using nanoscale device

June 3, 2021 By Brian Buntz

beta cells

Scientists at Washington University (St. Louis) and Cornell University (Ithaca, N.Y.) successfully implanted insulin-secreting cells in mice with type 1 diabetes. The cells proved capable of reversing chemically-induced diabetes for up to 200 days after implantation, according to a recent article in Science Translational Medicine.  To do so, they used a nanofiber-integrated cell encapsulation (NICE) device […]

Filed Under: Diabetes, Hydrogels Tagged With: Diabetes, insulin, nanofiber-integrated cell encapsulation, NICE

Medtronic launches 7-day infusion set for diabetes in Europe

April 14, 2021 By Sean Whooley

Medtronic Extended infusion set

Medtronic (NYSE:MDT) announced today that it launched the Medtronic Extended infusion set for diabetes in select European countries. Fridley, Minn.–based Medtronic touts the Extended infusion set as the first and only infusion set that a diabetes patient can wear for up to seven days, as most typically infusion pumps that deliver insulin to the body […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: insulin, Medtronic

DTW Podcast: Insulet CEO Petrovic sees abundance of CGM opportunities

March 17, 2021 By Tom Salemi

Insulet CEO Shacey Petrovic DTW Podcast DeviceTalks Weekly

Medtech startups developing continuous glucose monitors have caught the eye of at least one potential – and powerful – partner – Insulet. In an interview with the DeviceTalks Weekly Podcast, CEO Shacey Petrovic said the maker of the OmniPod insulin-delivery device sees partnering with other companies as the likely path to creating a single device […]

Filed Under: Diabetes, Drug-Device Combinations, Featured Tagged With: DeviceTalks, DeviceTalks Weekly, Insulet, insulin

Canada approves Tandem Diabetes Caree’s advanced hybrid closed-loop insulin pump

November 23, 2020 By Chris Newmarker

Tandem Diabetes Care

Tandem Diabetes Care (NSDQ:TNDM) announced today that Health Canada has approved its t:slim X2 insulin pump with Control-IQ technology. The news comes nearly a year after the U.S. launch of the t:slim X2 with Control-IQ. All in-warranty t:slim X2 pump users in Canada will be able to add Control-IQ technology to their existing pump via a […]

Filed Under: Diabetes, Featured Tagged With: Health Canada, insulin, Tandem Diabetes Care

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS